Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.020
-0.060 (-5.56%)
At close: Dec 1, 2025, 4:00 PM EST
1.000
-0.020 (-1.96%)
After-hours: Dec 1, 2025, 7:07 PM EST
Accuray Revenue
Accuray had revenue of $93.94M in the quarter ending September 30, 2025, a decrease of -7.49%. This brings the company's revenue in the last twelve months to $450.90M, up 1.51% year-over-year. In the fiscal year ending June 30, 2025, Accuray had annual revenue of $458.51M with 2.68% growth.
Revenue (ttm)
$450.90M
Revenue Growth
+1.51%
P/S Ratio
0.24
Revenue / Employee
$455,457
Employees
990
Market Cap
115.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 458.51M | 11.95M | 2.68% |
| Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
| Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
| Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
| Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ARAY News
- 25 days ago - Accuray's Latest Transformation Attempt Could Be Too Little Too Late - Seeking Alpha
- 26 days ago - Accuray Incorporated (ARAY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Accuray Reports Fiscal 2026 First Quarter Financial Results - PRNewsWire
- 4 weeks ago - Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules - PRNewsWire
- 4 weeks ago - Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025 - PRNewsWire
- 6 weeks ago - Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth - PRNewsWire
- 7 weeks ago - Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System - PRNewsWire
- 2 months ago - Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care - PRNewsWire